Order Article Reprints

Peng G, Tsukamoto S, Umehara Y, Kishi R, Tominaga M, Takamori K, Okumura K, Ogawa H, Ikeda S, Niyonsaba F. Experimental and Clinical Evidence Suggests That Treatment with Betacellulin Can Alleviate Th2-Type Cytokine-Mediated Impairment of Skin Barrier Function. International Journal of Molecular Sciences. 2022; 23(19):11520. https://doi.org/10.3390/ijms231911520

Peng, Ge, Saya Tsukamoto, Yoshie Umehara, Ryoma Kishi, Mitsutoshi Tominaga, Kenji Takamori, Ko Okumura, Hideoki Ogawa, Shigaku Ikeda, and François Niyonsaba. 2022. "Experimental and Clinical Evidence Suggests That Treatment with Betacellulin Can Alleviate Th2-Type Cytokine-Mediated Impairment of Skin Barrier Function" International Journal of Molecular Sciences 23, no. 19: 11520. https://doi.org/10.3390/ijms231911520

Peng, G., Tsukamoto, S., Umehara, Y., Kishi, R., Tominaga, M., Takamori, K., Okumura, K., Ogawa, H., Ikeda, S., & Niyonsaba, F. (2022). Experimental and Clinical Evidence Suggests That Treatment with Betacellulin Can Alleviate Th2-Type Cytokine-Mediated Impairment of Skin Barrier Function. International Journal of Molecular Sciences, 23(19), 11520. https://doi.org/10.3390/ijms231911520